dc.contributor.author | Crawley, D | |
dc.contributor.author | Chandra, A | |
dc.contributor.author | Loda, M | |
dc.contributor.author | Gillett, C | |
dc.contributor.author | Cathcart, P | |
dc.contributor.author | Challacombe, B | |
dc.contributor.author | Cook, G | |
dc.contributor.author | Cahill, D | |
dc.contributor.author | Santa Olalla, A | |
dc.contributor.author | Cahill, F | |
dc.contributor.author | George, G | |
dc.contributor.author | Rudman, S | |
dc.contributor.author | Van Hemelrijck, M | |
dc.date.accessioned | 2018-03-05T15:01:29Z | |
dc.date.issued | 2017-12 | |
dc.identifier | 494 | |
dc.identifier.citation | BMC Cancer, 2017, 17 (1) | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/1551 | |
dc.identifier.eissn | 1471-2407 | |
dc.identifier.doi | 10.1186/s12885-017-3458-3 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | Springer Science and Business Media LLC | |
dc.title | Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1186/s12885-017-3458-3 | |
rioxxterms.licenseref.startdate | 2017-12 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | BMC Cancer | |
pubs.issue | 1 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 17 | |
pubs.embargo.terms | Not known | |
dc.contributor.icrauthor | Marsden, | en |